HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model.
Saved in:
| Title: | HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model. |
|---|---|
| Authors: | Zeng W; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China., Kwan Law BY; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China., Wai Wong VK; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China., Bik Chan DS; Athenex Hong Kong Innovative Limited, Hong Kong, China., Fai Mok SW; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.; Faculty of Medicine, Macau University of Science and Technology, Macau, China., Ying Gao JJ; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China., Yan Ho RK; Faculty of Medicine, Macau University of Science and Technology, Macau, China., Liang X; Athenex Hong Kong Innovative Limited, Hong Kong, China., Li JH; Athenex Hong Kong Innovative Limited, Hong Kong, China., Lee MT; Athenex Hong Kong Innovative Limited, Hong Kong, China., Yoon WL; Athenex Hong Kong Innovative Limited, Hong Kong, China., Smolinski MP; Athenex Inc., New York 14203, USA., Nam Lau JY; Athenex Hong Kong Innovative Limited, Hong Kong, China., Kei Lam CW; Faculty of Medicine, Macau University of Science and Technology, Macau, China., Fok M; Faculty of Medicine, Macau University of Science and Technology, Macau, China. |
| Source: | Cancer biology & medicine [Cancer Biol Med] 2020 Nov 15; Vol. 17 (4), pp. 986-1001. Date of Electronic Publication: 2020 Dec 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2095-3941 (Print) Linking ISSN: 20953941 NLM ISO Abbreviation: Cancer Biol Med |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33299648 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zeng+W%22">Zeng W</searchLink>; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Kwan+Law+BY%22">Kwan Law BY</searchLink>; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Wai+Wong+VK%22">Wai Wong VK</searchLink>; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Bik+Chan+DS%22">Bik Chan DS</searchLink>; Athenex Hong Kong Innovative Limited, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Fai+Mok+SW%22">Fai Mok SW</searchLink>; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.; Faculty of Medicine, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Ying+Gao+JJ%22">Ying Gao JJ</searchLink>; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Yan+Ho+RK%22">Yan Ho RK</searchLink>; Faculty of Medicine, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Athenex Hong Kong Innovative Limited, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Li+JH%22">Li JH</searchLink>; Athenex Hong Kong Innovative Limited, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Lee+MT%22">Lee MT</searchLink>; Athenex Hong Kong Innovative Limited, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Yoon+WL%22">Yoon WL</searchLink>; Athenex Hong Kong Innovative Limited, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Smolinski+MP%22">Smolinski MP</searchLink>; Athenex Inc., New York 14203, USA.<br /><searchLink fieldCode="AU" term="%22Nam+Lau+JY%22">Nam Lau JY</searchLink>; Athenex Hong Kong Innovative Limited, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Kei+Lam+CW%22">Kei Lam CW</searchLink>; Faculty of Medicine, Macau University of Science and Technology, Macau, China.<br /><searchLink fieldCode="AU" term="%22Fok+M%22">Fok M</searchLink>; Faculty of Medicine, Macau University of Science and Technology, Macau, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101588850%22">Cancer biology & medicine</searchLink> [Cancer Biol Med] 2020 Nov 15; Vol. 17 (4), pp. 986-1001. <i>Date of Electronic Publication: </i>2020 Dec 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Chinese+Anti-Cancer+Association%22">Chinese Anti-Cancer Association </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101588850 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2095-3941 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220953941%22">20953941 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Biol Med |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33299648 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.20892/j.issn.2095-3941.2020.0128 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 986 Titles: – TitleFull: HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zeng W – PersonEntity: Name: NameFull: Kwan Law BY – PersonEntity: Name: NameFull: Wai Wong VK – PersonEntity: Name: NameFull: Bik Chan DS – PersonEntity: Name: NameFull: Fai Mok SW – PersonEntity: Name: NameFull: Ying Gao JJ – PersonEntity: Name: NameFull: Yan Ho RK – PersonEntity: Name: NameFull: Liang X – PersonEntity: Name: NameFull: Li JH – PersonEntity: Name: NameFull: Lee MT – PersonEntity: Name: NameFull: Yoon WL – PersonEntity: Name: NameFull: Smolinski MP – PersonEntity: Name: NameFull: Nam Lau JY – PersonEntity: Name: NameFull: Kei Lam CW – PersonEntity: Name: NameFull: Fok M IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2020 Nov 15 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 2095-3941 Numbering: – Type: volume Value: 17 – Type: issue Value: 4 Titles: – TitleFull: Cancer biology & medicine Type: main |
| ResultId | 1 |
